- Home
- HOLO vs OGEN Comparison
HOLO vs OGEN Comparison
Compare HOLO & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOLO
- OGEN
- Stock Information
- Founded
- HOLO 2018
- OGEN 1996
- Country
- HOLO China
- OGEN United States
- Employees
- HOLO N/A
- OGEN N/A
- Industry
- HOLO Computer Software: Programming Data Processing
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- HOLO Technology
- OGEN Health Care
- Exchange
- HOLO Nasdaq
- OGEN Nasdaq
- Market Cap
- HOLO 95.5M
- OGEN 4.5M
- IPO Year
- HOLO N/A
- OGEN N/A
- Fundamental
- Price
- HOLO $4.47
- OGEN $0.34
- Analyst Decision
- HOLO
- OGEN
- Analyst Count
- HOLO 0
- OGEN 0
- Target Price
- HOLO N/A
- OGEN N/A
- AVG Volume (30 Days)
- HOLO 5.0M
- OGEN 392.1K
- Earning Date
- HOLO 10-29-2024
- OGEN 11-07-2024
- Dividend Yield
- HOLO N/A
- OGEN N/A
- EPS Growth
- HOLO N/A
- OGEN N/A
- EPS
- HOLO N/A
- OGEN N/A
- Revenue
- HOLO $32,242,196.00
- OGEN $7,466.00
- Revenue This Year
- HOLO N/A
- OGEN N/A
- Revenue Next Year
- HOLO N/A
- OGEN N/A
- P/E Ratio
- HOLO N/A
- OGEN N/A
- Revenue Growth
- HOLO 326.95
- OGEN N/A
- 52 Week Low
- HOLO $4.00
- OGEN $0.29
- 52 Week High
- HOLO $1,968.00
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- HOLO 41.41
- OGEN 36.96
- Support Level
- HOLO $4.83
- OGEN $0.29
- Resistance Level
- HOLO $6.01
- OGEN $0.35
- Average True Range (ATR)
- HOLO 0.92
- OGEN 0.04
- MACD
- HOLO -0.05
- OGEN 0.02
- Stochastic Oscillator
- HOLO 4.86
- OGEN 31.19
About HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.